| 000 | 01232 a2200325 4500 | ||
|---|---|---|---|
| 005 | 20250513115141.0 | ||
| 264 | 0 | _c19970714 | |
| 008 | 199707s 0 0 eng d | ||
| 022 | _a0920-3206 | ||
| 024 | 7 |
_a10.1007/BF00051616 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aEpstein, M | |
| 245 | 0 | 0 |
_aCalcium channel blockers and hypertension: evolving perspective--1996. _h[electronic resource] |
| 260 |
_bCardiovascular drugs and therapy _cJan 1997 |
||
| 300 |
_a883-91 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 |
_aAntihypertensive Agents _xadministration & dosage |
| 650 | 0 | 4 |
_aBlood Pressure _xdrug effects |
| 650 | 0 | 4 |
_aCalcium Channel Blockers _xadministration & dosage |
| 650 | 0 | 4 | _aDelayed-Action Preparations |
| 650 | 0 | 4 |
_aHeart _xdrug effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHypertension _xdrug therapy |
| 650 | 0 | 4 |
_aHypertrophy, Left Ventricular _xdrug therapy |
| 650 | 0 | 4 |
_aKidney _xdrug effects |
| 650 | 0 | 4 |
_aRenal Circulation _xdrug effects |
| 650 | 0 | 4 |
_aVascular Resistance _xdrug effects |
| 773 | 0 |
_tCardiovascular drugs and therapy _gvol. 10 Suppl 3 _gp. 883-91 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/BF00051616 _zAvailable from publisher's website |
| 999 |
_c9108203 _d9108203 |
||